News | FDA

Top News

Number of FDA BIMO Inspections Decreased in FY 2019

Full Article

June 28, 2020
Appeals Court Upholds Invalidation of Rule Requiring Price Disclosures in DTC TV Ads

Full Article

June 18, 2020
Chipotle To Pay Record $25 Million Criminal Fine, Enters into DPA To Resolve Food Adulteration Charges

Full Article

April 22, 2020
Coronavirus Diagnostic Testing: What the FDA Expects for LDTs, Commercial Test Kits, Serological Tests

Full Article

April 16, 2020
FDA Postpones Most Domestic and Foreign Inspections Because of COVID-19 Public Health Emergency

Full Article

March 18, 2020

LATEST HEADLINES

FDA Guidance Examines Key COVID-19 Vaccine Trial Issues

July 3, 2020
Novartis Pays Nearly $700 Million To Settle Speaker Program and Co-Pay Cases

July 3, 2020
Public Citizen Blasts FDA’s Approval, Clearance and Oversight of Implanted Spinal Cord Stimulators

July 2, 2020
Novartis, Subsidiaries Settle Foreign Corrupt Practices Act Allegations for Over $345 Million

July 1, 2020
Number of FDA BIMO Inspections Decreased in FY 2019

June 28, 2020
Feds Charge Regeneron with Providing Kickbacks Through Foundation Covering Medicare Co-pays

June 26, 2020
AMS Proposes To Add Three Substances to Organic Substances List

June 25, 2020
Supreme Court Decision on SEC Disgorgement May Lead to Limitations on the Remedy in FDA, FTC Actions

June 24, 2020
CDRH, CDER Provide Guidance on COVID-19’s Effect on Regulatory, Policy Issues Related to Devices

June 24, 2020
Sponsors Need To Plan for COVID-19's Effect on Clinical Trial Objectives

June 19, 2020

Latest FDA Intelligence

Converting Promotions To Digital Formats Require Special Considerations

June 21, 2020
Ready for Virtual FDA Inspections? Agency, Industry Face the Possibility as Pandemic Continues

May 20, 2020
COVID-19 Changes Medical Product Marketing Fundamentally

May 13, 2020
Move to Telemedicine Will Change Promotion Approaches

April 17, 2020
OPDP Shows Concern About Lack of Risk Information in Electronic Communications

March 15, 2020

NEWSLETTERS

Array
(
    [_sf2_attributes] => Array
        (
        )

    [_symfony_flashes] => Array
        (
        )

    [_sf2_meta] => Array
        (
            [u] => 1593934353
            [c] => 1593934353
            [l] => 2000000
        )

)

Array
(
    [_sf2_attributes] => Array
        (
        )

    [_symfony_flashes] => Array
        (
        )

    [_sf2_meta] => Array
        (
            [u] => 1593934353
            [c] => 1593934353
            [l] => 2000000
        )

    [fda] => Array
        (
            [last_user_access] => 
        )

)

Array
(
    [_sf2_attributes] => Array
        (
        )

    [_symfony_flashes] => Array
        (
        )

    [_sf2_meta] => Array
        (
            [u] => 1593934353
            [c] => 1593934353
            [l] => 2000000
        )

    [fda] => Array
        (
            [last_user_access] => 
        )

)

Array
(
    [_sf2_attributes] => Array
        (
        )

    [_symfony_flashes] => Array
        (
        )

    [_sf2_meta] => Array
        (
            [u] => 1593934353
            [c] => 1593934353
            [l] => 2000000
        )

    [fda] => Array
        (
            [last_user_access] => 
        )

)

Array
(
    [_sf2_attributes] => Array
        (
        )

    [_symfony_flashes] => Array
        (
        )

    [_sf2_meta] => Array
        (
            [u] => 1593934353
            [c] => 1593934353
            [l] => 2000000
        )

    [fda] => Array
        (
            [last_user_access] => 
        )

)

Top News

Number of FDA BIMO Inspections Decreased in FY 2019

Appeals Court Upholds Invalidation of Rule Requiring Price Disclosures in DTC TV Ads

Chipotle To Pay Record $25 Million Criminal Fine, Enters into DPA To Resolve Food Adulteration Charges

Coronavirus Diagnostic Testing: What the FDA Expects for LDTs, Commercial Test Kits, Serological Tests

FDA Postpones Most Domestic and Foreign Inspections Because of COVID-19 Public Health Emergency

LATEST HEADLINES

Latest FDA Intelligence

Converting Promotions To Digital Formats Require Special Considerations

Ready for Virtual FDA Inspections? Agency, Industry Face the Possibility as Pandemic Continues

COVID-19 Changes Medical Product Marketing Fundamentally

Move to Telemedicine Will Change Promotion Approaches

OPDP Shows Concern About Lack of Risk Information in Electronic Communications

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT